BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9234890)

  • 1. Association of antithrombotic factor deficiencies and hypofibrinolysis with Legg-Perthes disease.
    Kahle WK
    J Bone Joint Surg Am; 1997 Jul; 79(7):1114; author reply 1114-5. PubMed ID: 9234890
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of antithrombotic factor deficiencies and hypofibrinolysis with Legg-Perthes disease.
    Herndon WA
    J Bone Joint Surg Am; 1997 Jul; 79(7):1114-5. PubMed ID: 9234891
    [No Abstract]   [Full Text] [Related]  

  • 3. Association of antithrombotic factor deficiencies and hypofibrinolysis with Legg-Perthes disease.
    Glueck CJ; Crawford A; Roy D; Freiberg R; Glueck H; Stroop D
    J Bone Joint Surg Am; 1996 Jan; 78(1):3-13. PubMed ID: 8550676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulation abnormalities in Legg-Calvé-Perthes disease.
    Vosmaer A; Pereira RR; Koenderman JS; Rosendaal FR; Cannegieter SC
    J Bone Joint Surg Am; 2010 Jan; 92(1):121-8. PubMed ID: 20048104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein C and S deficiency, thrombophilia, and hypofibrinolysis: pathophysiologic causes of Legg-Perthes disease.
    Glueck CJ; Glueck HI; Greenfield D; Freiberg R; Kahn A; Hamer T; Stroop D; Tracy T
    Pediatr Res; 1994 Apr; 35(4 Pt 1):383-8. PubMed ID: 8047373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of antithrombotic factor deficiencies and hypofibrinolysis with Legg-Perthes disease (78-A: 3-13, Jan. 1996).
    Hunt DM; Holmes Z; Pickering W; Cohen H
    J Bone Joint Surg Am; 1998 Apr; 80(4):604-6. PubMed ID: 9563392
    [No Abstract]   [Full Text] [Related]  

  • 7. Prospective reevaluation of the association between thrombotic diathesis and legg-perthes disease.
    Hresko MT; McDougall PA; Gorlin JB; Vamvakas EC; Kasser JR; Neufeld EJ
    J Bone Joint Surg Am; 2002 Sep; 84(9):1613-8. PubMed ID: 12208918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of thrombotic and fibrinolytic disorders in the etiology of Perthes' disease.
    Koo KH; Song HR; Ha YC; Kim JR; Kim SJ; Kim KI; Chang KC; Ahn IO; Cho SH
    Clin Orthop Relat Res; 2002 Jun; (399):162-7. PubMed ID: 12011705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to activated protein C and Legg-Perthes disease.
    Glueck CJ; Brandt G; Gruppo R; Crawford A; Roy D; Tracy T; Stroop D; Wang P; Becker A
    Clin Orthop Relat Res; 1997 May; (338):139-52. PubMed ID: 9170375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Deficiencies of physiological coagulation inhibitors in children with venous thromboses of the lower limbs. Prospective study of 6 cases].
    Khaldi F; Toumi NH; Ben Jaballah N; Zriba S; Ben Naceur B
    Ann Pediatr (Paris); 1993 Jun; 40(6):348-52. PubMed ID: 8352495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of protein C, protein S, and resistance to activated protein C in Legg-Perthes disease.
    Eldridge J; Dilley A; Austin H; EL-Jamil M; Wolstein L; Doris J; Hooper WC; Meehan PL; Evatt B
    Pediatrics; 2001 Jun; 107(6):1329-34. PubMed ID: 11389252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of congenital prethrombotic disorders in children with Legg-Perthes disease.
    Sirvent N; Fisher F; el Hayek T; Appert A; Giudicelli H; Griffet J
    J Pediatr Orthop B; 2000 Jan; 9(1):24-7. PubMed ID: 10647105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of inherited thrombotic disorders in the etiology of Legg-Calvé-Perthes disease.
    Gallistl S; Reitinger T; Linhart W; Muntean W
    J Pediatr Orthop; 1999; 19(1):82-3. PubMed ID: 9890293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Congenital disorders of hemostasis in children with Perthes disease].
    Kandzierski G; Malek U; Gregosiewicz A; Okoński M; Filiks-Litwin B; Drabko K
    Chir Narzadow Ruchu Ortop Pol; 2004; 69(4):225-7. PubMed ID: 15587376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of coagulation abnormalities in the development of Perthes' disease.
    Kealey WD; Mayne EE; McDonald W; Murray P; Cosgrove AP
    J Bone Joint Surg Br; 2000 Jul; 82(5):744-6. PubMed ID: 10963178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prothrombin Time and Coagulation Factor IX as Hemostatic Risk Markers for Legg- Calvé-Perthes Disease.
    Hernández-Zamora E; Rodríguez-Olivas AO; Rosales-Cruz E; Galicia-Alvarado MA; Zavala-Hernández C; Reyes-Maldonado E
    Clin Appl Thromb Hemost; 2023; 29():10760296221151166. PubMed ID: 36650707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of blood clotting factor activities in canine Legg-Calvé-Perthes' disease.
    Brenig B; Leeb T; Jansen S; Kopp T
    J Vet Intern Med; 1999; 13(6):570-3. PubMed ID: 10587258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Legg-Perthes-Calvé disease and disorders of hemostasis].
    Léonard JC; Morin C; Bianchi F; Drouvin F
    Arch Pediatr; 2002 Feb; 9(2):221-2. PubMed ID: 11915508
    [No Abstract]   [Full Text] [Related]  

  • 19. [Acquired deficiency in the system of proteins C and S and acute myocardial infarction].
    Riabov VV; Stoliarov VA; Kapilevich NA; Gerbolinskaia TA; Markov VA
    Ter Arkh; 2004; 76(6):93-4. PubMed ID: 15332588
    [No Abstract]   [Full Text] [Related]  

  • 20. Protein C levels in patients with Legg-Calve-Perthes disease: is it a true deficiency?
    Mehta JS; Conybeare ME; Hinves BL; Winter JB
    J Pediatr Orthop; 2006; 26(2):200-3. PubMed ID: 16557135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.